• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝静脉闭塞性疾病可能是系统性淀粉样变性肝脏受累的一种罕见特征:病例报告及文献综述。

Hepatic veno-occlusive disease may be a rare characteristic of hepatic involvement in systemic amyloidosis: case report and literature review.

作者信息

Zhu Tong-Yin, Zhou Guan-Hui, Chen Xin-Hua, Teng Xiao-Dong, Sun Jun-Hui

机构信息

Hepatobiliary and Pancreatic Interventional Treatment Center, Division of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Hangzhou, China.

出版信息

J Int Med Res. 2020 Feb;48(2):300060520904857. doi: 10.1177/0300060520904857.

DOI:10.1177/0300060520904857
PMID:32090649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7110914/
Abstract

Systemic amyloidosis is a rare disease and patients with hepatic amyloidosis often present with hepatomegaly. Hepatomegaly can also be a feature of hepatic veno-occlusive disease (HVOD). We report here a case of systemic amyloidosis in a patient who was suspected of having HVOD. On the basis of computed tomography findings in the abdomen, HVOD was initially suspected in a 63-year-old man with the chief complaint of upper abdominal pain, ascites, and weight loss. Multiple patchy purpura and nerve symptoms were identified and these were due to amyloidosis. An increase in proteinuria and immunoglobulin κ light-chain levels, and thickening of the ventricular wall supported the diagnosis of systemic light-chain amyloidosis involving the liver, heart, kidney, skin, and nerves. This diagnosis was confirmed by histological examination of a bone marrow core biopsy with Congo red dye. Sequential treatment of bortezomib and dexamethasone led to good results in the patient. Findings of this rare case indicate that HVOD can be diagnosed without a definite history of hematopoietic stem cell transplantation or pyrrolizidine alkaloid ingestion, but more evidence is required to make an accurate diagnosis. Importantly, we speculate that HVOD is a rare characteristic of liver involvement in systemic amyloidosis.

摘要

系统性淀粉样变性是一种罕见疾病,肝淀粉样变性患者常表现为肝肿大。肝肿大也可能是肝静脉闭塞病(HVOD)的特征。我们在此报告一例疑似患有HVOD的系统性淀粉样变性患者。根据腹部计算机断层扫描结果,一名63岁男性因上腹部疼痛、腹水和体重减轻为主诉,最初被怀疑患有HVOD。发现多处斑片状紫癜和神经症状,这些是由淀粉样变性引起的。蛋白尿和免疫球蛋白κ轻链水平升高以及心室壁增厚支持了累及肝脏、心脏、肾脏、皮肤和神经的系统性轻链淀粉样变性的诊断。通过刚果红染色的骨髓芯活检组织学检查证实了这一诊断。硼替佐米和地塞米松的序贯治疗使该患者取得了良好效果。这一罕见病例的发现表明,无需明确的造血干细胞移植或吡咯里西啶生物碱摄入史即可诊断HVOD,但需要更多证据才能做出准确诊断。重要的是,我们推测HVOD是系统性淀粉样变性肝脏受累的一种罕见特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/7110914/5433866b1312/10.1177_0300060520904857-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/7110914/b321b041fcab/10.1177_0300060520904857-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/7110914/31389487edbe/10.1177_0300060520904857-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/7110914/5433866b1312/10.1177_0300060520904857-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/7110914/b321b041fcab/10.1177_0300060520904857-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/7110914/31389487edbe/10.1177_0300060520904857-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2558/7110914/5433866b1312/10.1177_0300060520904857-fig3.jpg

相似文献

1
Hepatic veno-occlusive disease may be a rare characteristic of hepatic involvement in systemic amyloidosis: case report and literature review.肝静脉闭塞性疾病可能是系统性淀粉样变性肝脏受累的一种罕见特征:病例报告及文献综述。
J Int Med Res. 2020 Feb;48(2):300060520904857. doi: 10.1177/0300060520904857.
2
Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms.骨髓移植后肝静脉闭塞病:临床症状和体征的组织学关联
Hepatology. 1994 May;19(5):1171-81.
3
Hepatic veno-occlusive disease following peripheral blood stem cell or bone marrow transplantation.外周血干细胞或骨髓移植后肝静脉闭塞病
Haematologica. 1999 Jun;84 Suppl EHA-4:40-3.
4
Primary systemic amyloidosis with skin and cardiac involvement: a case report.原发性系统性淀粉样变性伴皮肤和心脏受累:一例报告。
Acta Dermatovenerol Alp Pannonica Adriat. 2018 Mar;27(1):45-47.
5
Computed tomography findings of hepatic veno-occlusive disease caused by Sedum aizoon with histopathological correlation.景天三七所致肝静脉闭塞病的计算机断层扫描表现及其与组织病理学的相关性
Braz J Med Biol Res. 2015 Dec;48(12):1145-50. doi: 10.1590/1414-431X20154563.
6
Successful treatment with danhong injection for hepatic veno-occlusive disease.丹红注射液成功治疗肝静脉闭塞病。
Hepatogastroenterology. 2011 May-Jun;58(107-108):992-5.
7
Veno-occlusive disease of liver: a case series from eastern Rajasthan.肝静脉闭塞病:来自拉贾斯坦邦东部的病例系列
Indian Pediatr. 2002 May;39(5):491-4.
8
[The value of MSCT and MRI in the diagnosis of hepatic veno-occlusive disease].多层螺旋CT和磁共振成像在肝静脉闭塞病诊断中的价值
Zhonghua Gan Zang Bing Za Zhi. 2010 Feb;18(2):150-2. doi: 10.3760/cma.j.issn.1007-3418.2010.02.018.
9
A case report of hepatic veno-occlusive disease after ingesting dainties.一例食用美味佳肴后发生肝静脉闭塞病的病例报告。
World J Gastroenterol. 2006 Nov 7;12(41):6734-5. doi: 10.3748/wjg.v12.i41.6734.
10
[An unusual presentation of Amyloidosis AL].
G Ital Nefrol. 2018 May;35(3).

本文引用的文献

1
Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease.吡咯里西啶生物碱相关肝静脉闭塞病的临床特征和治疗。
Liver Int. 2018 Oct;38(10):1867-1874. doi: 10.1111/liv.13684. Epub 2018 Feb 11.
2
CT Features of Hepatic Veno-occlusive Disease: A Meta-analysis.肝脏静脉闭塞病的 CT 特征:一项荟萃分析。
Acad Radiol. 2018 Mar;25(3):328-337. doi: 10.1016/j.acra.2017.10.012. Epub 2017 Nov 27.
3
Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis.
Expert Opin Ther Targets. 2017 Dec;21(12):1095-1110. doi: 10.1080/14728222.2017.1398235.
4
Imaging for abdominal involvement in amyloidosis.淀粉样变性腹部受累的影像学检查
Diagn Interv Radiol. 2017 Jul-Aug;23(4):282-285. doi: 10.5152/dir.2017.16484.
5
New and developing therapies for AL amyloidosis.治疗AL淀粉样变性的新型及正在研发的疗法。
Expert Opin Pharmacother. 2017 Feb;18(2):139-149. doi: 10.1080/14656566.2016.1274971. Epub 2016 Dec 29.
6
Liver Transplantation Is a Potential Treatment Option for Systemic Light Chain Amyloidosis Patients with Dominant Hepatic Involvement: A Case Report and Analytical Review of the Literature.肝移植是主要肝脏受累的系统性轻链淀粉样变性患者的一种潜在治疗选择:一例病例报告及文献分析综述
Intern Med. 2016;55(12):1585-90. doi: 10.2169/internalmedicine.55.6675. Epub 2016 Jun 15.
7
A practical approach to the diagnosis of systemic amyloidoses.系统性淀粉样变的诊断实用方法。
Blood. 2015 Apr 2;125(14):2239-44. doi: 10.1182/blood-2014-11-609883. Epub 2015 Jan 30.
8
Pathophysiology and treatment of systemic amyloidosis.系统性淀粉样变性的病理生理学和治疗。
Nat Rev Nephrol. 2013 Oct;9(10):574-86. doi: 10.1038/nrneph.2013.171. Epub 2013 Aug 27.
9
Systemic light chain amyloidosis: an update for treating physicians.系统性轻链淀粉样变:治疗医师的最新进展。
Blood. 2013 Jun 27;121(26):5124-30. doi: 10.1182/blood-2013-01-453001. Epub 2013 May 13.
10
Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study.每周一次和每周两次硼替佐米治疗复发系统性 AL 淀粉样变性患者的疗效和安全性:一项 1/2 期研究的结果。
Blood. 2011 Jul 28;118(4):865-73. doi: 10.1182/blood-2011-02-334227. Epub 2011 May 11.